President Donald Trump, accompanied by U.S. Secretary of State Marco Rubio (L) and U.S. Defense Secretary Pete Hegseth (R), discusses his decorating of the Cabinet Room during a cabinet meeting at the White House on July 08, 2025 in Washington, DC.Andrew Harnik | Getty ImagesPresident Donald Trump signaled he would send more letters Wednesday dictating new U.S. tariff rates on a slew of countries’ imports, leaning into his aggressive approach to resetting America’s global trade relationships.The Trump administration “will be releasing a minimum of 7 Countries having to do with trade, tomorrow morning,” Trump wrote in a Truth Social post…
Author: usaeverydaylife
Nvidia CEO Jensen Huang attends a roundtable discussion at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris on June 11, 2025.Sarah Meyssonnier | ReutersNvidia shares jumped more than 2% on Wednesday, topping a $4 trillion market cap for the first time as investors scooped stock in the tech giant building the hardware for the generative artificial intelligence boom.The chipmaker is the first company to ever achieve this market value.Nvidia is the world’s most valuable company, surpassing Microsoft and Apple, both of which hit the $3 trillion mark before Nvidia. Microsoft is…
Dilara Irem Sancar | Anadolu | Getty ImagesIran’s oil minister on Wednesday criticized the effects of war-led disruptions to oil markets, weeks after Tehran’s 12-day hostilities with Israel sent crude price soaring.In remarks via videoconference for the OPEC seminar in Vienna, Mohsen Paknejad said, “Whatever the cause, an aggression of war that leads to the disruption of the supply of oil and gas resources to the international market imposes … complications on energy producers, and subjects national economies to hardships.””I believe we all need to take a principled stand against the resort to, and use of war, as a tool…
Shares of JPMorgan along with other large-cap and large regional banks could be due for gains in coming months according to Keefe, Bruyette & Woods, in contrast to a bearish call from HSBC that helped knock the stocks on Tuesday. On Wednesday, KBW, a firm that’s long specialized in covering financials, upgraded JPMorgan and Morgan Stanley to outperform from market perform, setting its price target for JPMorgan at $327, up from $253 and implying more than 27% upside from Tuesday’s close. Morgan Stanley’s 12-month price target moved to $160 from $127, which would translate into a 13% bump in the…
Close up of electrical engineer inspecting copper windings in an electrical engineering factory.Monty Rakusen | Digitalvision | Getty ImagesThe cost of copper for U.S. buyers has rocketed after President Donald Trump said he would impose a 50% tariff on imports of the metal.It means that already elevated prices are now even higher in the U.S. than elsewhere — and analysts warned of a hit to businesses and the wider U.S. economy as a result. The U.S. imports just under half of its copper, which is used in products ranging from machinery, electronics and household goods to housing and infrastructure projects. Trump’s stated…
The European Union (EU) is stuck in limbo as uncertainty persists around when a trade agreement with the U.S. might be reached.The goal had been to agree on a framework by July 9, when a temporary reprieve from U.S. President Donald Trump’s “reciprocal” tariffs was initially meant to expire. The EU was seemingly still working to this timeline earlier in the week.But that deadline has now passed — without the trading partners coming to an agreement.A framework may however still be established as soon as this week, Trump himself suggested Tuesday.”We’re probably two days off from sending them a letter.…
Investors may want to consider bracing for a weaker stock market performance over the next six months.According to Vanguard’s Roger Hallam, it’s prudent for long-term investors to have sufficient exposure to fixed income in this environment.”Our outlook for the second half of this year is that growth will slow,” the firm’s global head of rates told CNBC’s “ETF Edge” on Monday.Hallam predicts the labor market will continue to gradually cool while inflation rises. Hallam expects the Federal Reserve will ultimately prioritize jobs and cut interest rates toward the end of this year to provide insurance.”We think that will provide a…
Potential gains from artificial intelligence are still not fully baked into Microsoft , according to Oppenheimer. The firm upgraded Microsoft to outperform from perform. Its a $600 per share price target calls for nearly 21% upside from Tuesday’s close. Microsoft is one of the key bellwethers for the AI boom, given the company’s strategic partnership with ChatGPT parent-company OpenAI. “Investors’ attention on the ramp of Microsoft’s AI revenue stream will only increase as Azure’s growth remains strong, offering not only valuation support (akin to AWS underpinning Amazon’s valuation), but also upside potential as this revenue stream continues scaling fast and…
Check out the companies making headlines before the opening bell: Starbucks – Shares of the coffee chain jumped almost 2% after CNBC reported that Starbucks China has drawn bids for a potential stake sale that value the subsidiary at up to $10 billion. While shortlisting could be done in two months, the deal itself likely won’t be completed by the end of this year. AES – The stock jumped nearly 14% following a Bloomberg report that the energy company was exploring a potential sale amid interest from infrastructure investors. Verona Pharma — Shares surged 20% after Merck bought UK-based Verona…
Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug.Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, which generated nearly $30 billion in sales in 2024, but faces patent expiries starting in 2028.In response, the company has ramped up deal-making to broaden its revenue base. The latest deal is Merck’s largest since its $10.8 billion buyout of Prometheus Biosciences in 2023.It builds on the company’s portfolio of chronic lung…
